/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

J

Jean Hurteau

GlaxoSmithKline (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

14

Papers

89

Citations

1

h-index

1

i10-index

Jean Hurteau is an academic researcher from GlaxoSmithKline (United States). The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & PARP inhibition in cancer therapy & Renal Diseases and Glomerulopathies. The author has an h-index of 1, co-authored 12 publications.

Research Topics

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Renal Diseases and Glomerulopathies Economic and Financial Impacts of Cancer Angiogenesis and VEGF in Cancer

Papers by this author

works

What are the CA-125 testing rates and their clinical implications among patients with advanced ovarian cancer treated in real-world community practice?

2024 · Gynecologic Oncology · 1 citations

https://doi.org/10.1016/j.ygyno.2024.07.409

Linda Duska Maureen Cooney Zsófia Kiss Linda Kalilani

Identifying and breaking barriers for the treatment of gynecologic malignancies within the lesbian, gay, bisexual, transgender, queer/questioning, intersex and/or asexual community

2025 · Gynecologic Oncology · 0 citations

https://doi.org/10.1016/j.ygyno.2025.04.406

Bhavana Pothuri Michele Muir Jean Hurteau John U. Farley

Research topics

topics

Ovarian cancer diagnosis and treatment

PARP inhibition in cancer therapy

Renal Diseases and Glomerulopathies

Economic and Financial Impacts of Cancer

Angiogenesis and VEGF in Cancer

Chat about Author

Papers

Chat

Click to start Chat